Order Article Reprints

Tu J, Toh Y, Aldana AM, Wen JJ, Wu L, Jacob J, Li L, Pan S, Carmon KS, Liu QJ. Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics. 2024; 16(7):943. https://doi.org/10.3390/pharmaceutics16070943

Tu, Jianghua, Yukimatsu Toh, Adela M. Aldana, Jake J. Wen, Ling Wu, Joan Jacob, Li Li, Sheng Pan, Kendra S. Carmon, and Qingyun J. Liu. 2024. "Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma" Pharmaceutics 16, no. 7: 943. https://doi.org/10.3390/pharmaceutics16070943

Tu, J., Toh, Y., Aldana, A. M., Wen, J. J., Wu, L., Jacob, J., Li, L., Pan, S., Carmon, K. S., & Liu, Q. J. (2024). Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics, 16(7), 943. https://doi.org/10.3390/pharmaceutics16070943